Varian Selected to Provide First Proton Therapy System in Thailand
PALO ALTO, Calif., May 24, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR), today announced it has been selected through its distributor, Business Alignment, to supply and install a Varian ProBeam® Compact single-r... Devices, Oncology Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 24, 2017 Category: Pharmaceuticals Source Type: news
World-first proton CT images create a new vision for cancer treatment
(University of Lincoln) An international team of scientists has produced the world's first computerized tomography (CT) images of biological tissue using protons -- a momentous step towards improving the quality and feasibility of Proton Therapy for cancer sufferers around the world. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2017 Category: International Medicine & Public Health Source Type: news
Japan approves Varian Medical ’ s ProBeam proton therapy
Varian Medical (NYSE:VAR) said today it won Shonin approval from the Japanese Ministry of Health, Labor and Welfare for its ProBeam system designed for proton therapy.
Proton therapy is designed for precise treatment of certain types of cancer while providing potentially fewer side effects than conventional radiation therapy, the Palo Alto, Calif.-based company said.
Varian claims that its ProBeam system is the 1st to offer fully-integrated intensity modulated proton therapy.
“We are very pleased that the ProBeam system has now received Shonin approval. This approval is an important step in the growing availability...
Source: Mass Device - May 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Oncology Regulatory/Compliance Varian Medical Systems Source Type: news
Toshiba, Japanese QST tout heavy-ion therapy breakthrough
Toshiba (TYO:6502) said today that it, along with Japan’s National Institutes for Quantum and Radiological Science and Technology have developed a novel pencil beaming scanning system which they claim significantly reduces the size of the system without lowered performance.
The company said that the newly designed system can be mounted on a rotating gantry with superconducing beam bending magnets, which will lead to further downsizing and weight reductions.
Toshiba said it will release more details of the device this week at the 56th Annual COnference of the Particle Therapy Co-operation group in Yokohama.
“T...
Source: Mass Device - May 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Oncology Research & Development Toshiba Source Type: news
IBA posts healthy Q1 revenue rise
Double-digit revenue increases in all its business segments propelled proton...Read more on AuntMinnie.comRelated Reading:
IBA posts healthy revenue for fiscal 2016
IBA, partners to bring proton therapy to Ala.
IBA, Nelco ink North American deal
Japan OKs IBA's proton therapy system
IBA reaches treatment milestone, wins UAE order (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 10, 2017 Category: Radiology Source Type: news
Varian ProBeam Proton Therapy System Receives Shonin Approval
Advanced proton therapy systems from Varian now available to cancer centers in Japan
PALO ALTO, Calif., May 10, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR) today announced it has received Shonin approval from th... Devices, Oncology, Regulatory Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 10, 2017 Category: Pharmaceuticals Source Type: news
7 medtech stories we missed this week: May 5, 2017
[Image from unsplash.com]From Biomerics’s $38.5 million expansion in Salt Lake City to new study results and partnerships, here are 7 medtech stories we missed this week but thought were still worth mentioning.
1. Biomerics opening new corporate HQ
Biomerics announced in a May 1 press release that it is moving its corporate headquarters in Salt Lake City. The new facility will be 230,000 sq. ft and will be located in the International Center. It will have corporate offices, engineering offices, research and development labs and cleanroom manufacturing. Biomerics is expected to invest $38.5 million in the expansion a...
Source: Mass Device - May 5, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Food & Drug Administration (FDA) Imaging Pre-Market Approval (PMA) Regulatory/Compliance Research & Development Accuray Inc. Biomerics Glytec medPhoton MedTech Mevion Medical Systems Neural Analytics RAPS Refocu Source Type: news
PET/CT helps assess pediatric brain tumor therapy
In a new study published in the May issue of the Journal of Nuclear Medicine,...Read more on AuntMinnie.comRelated Reading:
SNMMI: FDOPA-PET/MRI monitors pediatric brain tumors
SNMMI: PET, MRI may predict pediatric brain tumor outcomes
SNMMI: FET-PET aids pediatric brain cancer patients
SNM: PET/MRI helps tumor staging for pediatric patients
Proton therapy offers hope to pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 3, 2017 Category: Radiology Source Type: news
IMRT vs Proton Therapy in Esophageal Cancer
This video reviews the advantages and disadvantages of IMRT and proton therapy for the treatment of esophageal cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2017 Category: Cancer & Oncology Authors: Steven H. Lin, MD, PhD Tags: Videos Gastrointestinal Cancers Source Type: news
Mevion joins forces with MedPhoton
Proton therapy developer Mevion Medical Systems has inked a strategic agreement...Read more on AuntMinnie.comRelated Reading:
Mevion completes milestone installation
Mevion completes Fla. installation
Mevion, RaySearch partner on info system
Mevion to sharpen pencil-beam scanning at ASTRO
ProNova joins forces with MedPhoton (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 2, 2017 Category: Radiology Source Type: news
Proton therapy dev ProTom Int ’ l raises $30m
Proton therapy tech developer ProTom International said today it raised $30 million in a new round of funding.
The funding round will provide $30 million to the company by the end of June 2017, with $10 million already funded as of March, the company said in a press release.
ProTom produces the Radiance 330 proton therapy system, designed to offer focused proton therapy treatments to cancer patients. The company said that Massachusetts General Hospital is slated to install a Radiance 330 system, which it expects will be operational in late 2017.
“ProTom’s Radiance 33 is a disruptive technology that significant...
Source: Mass Device - April 7, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Oncology ProTom International Source Type: news
IBA Molecular forms Curium as new radiopharmacy player
Radiopharmacy vendor IBA Molecular has combined with recent acquisition Mallinckrodt...Read more on AuntMinnie.comRelated Reading:
IBA posts healthy revenue for fiscal 2016
IBA, partners to bring proton therapy to Ala.
IBA Molecular finalizes purchase of Mallinckrodt unit
IBA, Nelco ink North American deal
IBA cyclotron opens ahead of schedule (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2017 Category: Radiology Source Type: news
Varian Medical Systems Names New CFO
PALO ALTO, Calif., April 5, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR) today announced it has named Gary E. Bischoping, Jr. of Dell Technologies as Chief Financial Officer effective May 8, 2017. Bischoping, 49, will re... Devices, Oncology, Personnel Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2017 Category: Pharmaceuticals Source Type: news
From the room next door to the next planet over
The new Albert Chadwick Research Room inside the Roberts Proton Therapy Center is no ordinary laboratory space. In fact, there ’s nothing else quite like it anywhere else in the United States, and whether it’s treating patients with cancer or helping NASA with its plans to send astronauts to Mars, the discoveries that could propel scientists forward will happen right here. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news
Cancer therapy: Tracking real-time proton induced radiation chemistry in water
Proton therapy is a promising form of radiation treatment used to kill cancerous cells and effectively halt their rapid reproduction, and the fundamental understanding for it is contained in the radiation induced water chemistry that occurs immediately after the interaction. The ensuing processes are therefore a subject of considerable scientific interest. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news
